Drug Discovery Featured Articles & Applications

  1. Early Decisions That Shape Success In CNS Drug Development And Commercialization, Part 1 8/4/2026

    In part 1, we caught up with Ginger Johnson, SVP and neuroscience lead at Lumanity, to discuss how companies can connect the science to the realities of CNS drug development earlier

  2. The Changing Role Of Computational Mechanics In Drug Discovery 8/3/2026

    Computational models will never replace experimental biology, but their emerging role is different.

  3. Beyond Binder Design: Why AI's Next Frontier Is Designing Multispecific Antibodies 7/31/2026

    Many of the therapies with the greatest potential to improve patient outcomes are complex multispecifics, where the data simply doesn't exist.

  4. Drug Discovery AI Has A Ground Truth Problem 7/27/2026

    If the goal is more healthy years of life, the bottlenecks are target identification, target validation, and clinical testing. Why is AI not transforming those steps? Because the data are not there.

  5. Fragment-Based Drug Discovery 2.0, Part 2: Practical Workflow, Difficult Target Classes, And Emerging Capabilities 7/27/2026

    Part 2 focuses on the practical workflow, difficult target classes, emerging capabilities, and the criteria for translating these technologies into better discovery decisions.

  6. Chinese Competition And The Future Of Science: Insights From The U.S. Science Summit 7/24/2026

    At BiotechTV’s U.S. Science Summit, biotech leaders discussed China, AI, scientific storytelling, and what it will take to protect U.S. innovation.

  7. Fragment-Based Drug Discovery 2.0, Part 1: Faster, Cleaner Weak-Binding Hit Discovery 7/24/2026

    This article examines the advances in ¹⁹F NMR, ultra-high-field instrumentation, and contrast-engineered screening.

  8. From Path Dependency To Demonstrable Progress: FDA Modernization Act 3.0 7/23/2026

    With House passage of the FDA Modernization Act 3.0, Congress has taken another major step toward modernizing biomedical research and drug development.

  9. How AI-Powered Automation Is Redefining Pharmaceutical R&D 7/23/2026

    The autonomous lab is not a distant aspiration but a present-day competitive differentiator.

  10. Rethinking The Blueprint For Bone Regeneration: The Next Evolution In Orthobiologics 7/22/2026

    Next-generation orthobiologics could transform spinal fusion by enabling targeted bone regeneration, improving safety, and reducing reliance on traditional grafts and hardware.